ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹44 Cr | ₹46 Cr | ₹44 Cr | ₹49 Cr | ₹59 Cr |
What is the latest Total Non-Current Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹44 Cr |
| Mar2025 | ₹46 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹49 Cr |
| Mar2022 | ₹59 Cr |
How is Total Non-Current Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹44 Cr | -4.76 | |
| Mar2025 | ₹46 Cr | 5.70 | |
| Mar2024 | ₹44 Cr | -10.30 | |
| Mar2023 | ₹49 Cr | -17.87 | |
| Mar2022 | ₹59 Cr | - | |
Compare Total Non-Current Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,338.2 Cr | -1.8% | -4% | -3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.8% |
-4% |
-3.5% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses